194 related articles for article (PubMed ID: 21316197)
1. Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm.
Rivardo F; Martinotti MG; Turner RJ; Ceri H
Int J Antimicrob Agents; 2011 Apr; 37(4):324-31. PubMed ID: 21316197
[TBL] [Abstract][Full Text] [Related]
2. The activity of silver against Escherichia coli biofilm is increased by a lipopeptide biosurfactant.
Rivardo F; Martinotti MG; Turner RJ; Ceri H
Can J Microbiol; 2010 Mar; 56(3):272-8. PubMed ID: 20453915
[TBL] [Abstract][Full Text] [Related]
3. Anti-adhesion activity of two biosurfactants produced by Bacillus spp. prevents biofilm formation of human bacterial pathogens.
Rivardo F; Turner RJ; Allegrone G; Ceri H; Martinotti MG
Appl Microbiol Biotechnol; 2009 Jun; 83(3):541-53. PubMed ID: 19343338
[TBL] [Abstract][Full Text] [Related]
4. Biofilm inhibition and antimicrobial action of lipopeptide biosurfactant produced by heavy metal tolerant strain Bacillus cereus NK1.
Sriram MI; Kalishwaralal K; Deepak V; Gracerosepat R; Srisakthi K; Gurunathan S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):174-81. PubMed ID: 21458961
[TBL] [Abstract][Full Text] [Related]
5. Effects of the twin-arginine translocase on the structure and antimicrobial susceptibility of Escherichia coli biofilms.
Harrison JJ; Ceri H; Badry EA; Roper NJ; Tomlin KL; Turner RJ
Can J Microbiol; 2005 Aug; 51(8):671-83. PubMed ID: 16234865
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural stages of biofilm development of Escherichia coli on urethral catheters and effects of antibiotics on biofilm formation.
Koseoglu H; Aslan G; Esen N; Sen BH; Coban H
Urology; 2006 Nov; 68(5):942-6. PubMed ID: 17113884
[TBL] [Abstract][Full Text] [Related]
7. Application of lipopeptide biosurfactant isolated from a halophile: Bacillus tequilensis CH for inhibition of biofilm.
Pradhan AK; Pradhan N; Mall G; Panda HT; Sukla LB; Panda PK; Mishra BK
Appl Biochem Biotechnol; 2013 Nov; 171(6):1362-75. PubMed ID: 23955294
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
9. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae.
Verma V; Harjai K; Chhibber S
Biofouling; 2010 Aug; 26(6):729-37. PubMed ID: 20711894
[TBL] [Abstract][Full Text] [Related]
10. Effects of human serum albumin, ibuprofen and N-acetyl-L-cysteine against biofilm formation by pathogenic Escherichia coli strains.
Naves P; del Prado G; Huelves L; Rodríguez-Cerrato V; Ruiz V; Ponte MC; Soriano F
J Hosp Infect; 2010 Oct; 76(2):165-70. PubMed ID: 20615578
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of antibiotics on the autochthonous Escherichia coli of mice in the intestinal biofilm versus its planktonic phase.
Kétyi I
Acta Microbiol Immunol Hung; 1994; 41(2):189-95. PubMed ID: 7804722
[TBL] [Abstract][Full Text] [Related]
12. Disinfectant-like activity of lipopeptide biosurfactant produced by Bacillus tequilensis strain SDS21.
Singh AK; Sharma P
Colloids Surf B Biointerfaces; 2020 Jan; 185():110514. PubMed ID: 31639569
[TBL] [Abstract][Full Text] [Related]
13. Biofilm susceptibility to metal toxicity.
Harrison JJ; Ceri H; Stremick CA; Turner RJ
Environ Microbiol; 2004 Dec; 6(12):1220-7. PubMed ID: 15560820
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
[TBL] [Abstract][Full Text] [Related]
15. Lipopeptide biosurfactant from Bacillus thuringiensis pak2310: A potential antagonist against Fusarium oxysporum.
Deepak R; Jayapradha R
J Mycol Med; 2015 Mar; 25(1):e15-24. PubMed ID: 25456418
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial potential of a lipopeptide biosurfactant derived from a marine Bacillus circulans.
Das P; Mukherjee S; Sen R
J Appl Microbiol; 2008 Jun; 104(6):1675-84. PubMed ID: 18194244
[TBL] [Abstract][Full Text] [Related]
17. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
[TBL] [Abstract][Full Text] [Related]
18. Lipopeptide biosurfactants from Paenibacillus polymyxa inhibit single and mixed species biofilms.
Quinn GA; Maloy AP; McClean S; Carney B; Slater JW
Biofouling; 2012; 28(10):1151-66. PubMed ID: 23113815
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli serotype O157:H7 retention on solid surfaces and peroxide resistance is enhanced by dual-strain biofilm formation.
Uhlich GA; Rogers DP; Mosier DA
Foodborne Pathog Dis; 2010 Aug; 7(8):935-43. PubMed ID: 20367070
[TBL] [Abstract][Full Text] [Related]
20. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
